Thompson AJ - Search Results

1

A longitudinal study of abnormalities on MRI and disability from multiple sclerosis.

Brex PA, Ciccarelli O, O'Riordan JI, Sailer M, Thompson AJ, Miller DH. Brex PA, et al. Among authors: thompson aj. N Engl J Med. 2002 Jan 17;346(3):158-64. doi: 10.1056/NEJMoa011341. N Engl J Med. 2002. PMID: 11796849

2

beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1.

Zoukos Y, Leonard JP, Thomaides T, Thompson AJ, Cuzner ML. Zoukos Y, et al. Among authors: thompson aj. Ann Neurol. 1992 Jun;31(6):657-62. doi: 10.1002/ana.410310614. Ann Neurol. 1992. PMID: 1325138

3

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.

Miller DH, Thompson AJ, Morrissey SP, MacManus DG, Moore SG, Kendall BE, Moseley IF, McDonald WI. Miller DH, et al. Among authors: thompson aj. J Neurol Neurosurg Psychiatry. 1992 Jun;55(6):450-3. doi: 10.1136/jnnp.55.6.450. J Neurol Neurosurg Psychiatry. 1992. PMID: 1619410 Free PMC article.

4

Biochemical changes within a multiple sclerosis plaque in vivo.

Cadoux-Hudson TA, Kermode A, Rajagopalan B, Taylor D, Thompson AJ, Ormerod IE, McDonald WI, Radda GK. Cadoux-Hudson TA, et al. Among authors: thompson aj. J Neurol Neurosurg Psychiatry. 1991 Nov;54(11):1004-6. doi: 10.1136/jnnp.54.11.1004. J Neurol Neurosurg Psychiatry. 1991. PMID: 1666122 Free PMC article.

5

Multiple sclerosis and HLA: is the susceptibility gene really HLA-DR or -DQ?

Francis DA, Thompson AJ, Brookes P, Davey N, Lechler RI, McDonald WI, Batchelor JR. Francis DA, et al. Among authors: thompson aj. Hum Immunol. 1991 Oct;32(2):119-24. doi: 10.1016/0198-8859(91)90108-l. Hum Immunol. 1991. PMID: 1683865

6

Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration.

Thompson AJ, Miller D, Youl B, MacManus D, Moore S, Kingsley D, Kendall B, Feinstein A, McDonald WI. Thompson AJ, et al. Neurology. 1992 Jan;42(1):60-3. doi: 10.1212/wnl.42.1.60. Neurology. 1992. PMID: 1734325

7

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines.

Miller DH, Barkhof F, Berry I, Kappos L, Scotti G, Thompson AJ. Miller DH, et al. Among authors: thompson aj. J Neurol Neurosurg Psychiatry. 1991 Aug;54(8):683-8. doi: 10.1136/jnnp.54.8.683. J Neurol Neurosurg Psychiatry. 1991. PMID: 1940938 Free PMC article.

8

Neurological deterioration in young adults with phenylketonuria.

Thompson AJ, Smith I, Brenton D, Youl BD, Rylance G, Davidson DC, Kendall B, Lees AJ. Thompson AJ, et al. Lancet. 1990 Sep 8;336(8715):602-5. doi: 10.1016/0140-6736(90)93401-a. Lancet. 1990. PMID: 1975386

9

Major differences in the dynamics of primary and secondary progressive multiple sclerosis.

Thompson AJ, Kermode AG, Wicks D, MacManus DG, Kendall BE, Kingsley DP, McDonald WI. Thompson AJ, et al. Ann Neurol. 1991 Jan;29(1):53-62. doi: 10.1002/ana.410290111. Ann Neurol. 1991. PMID: 1996879

10

Destructive lesions in demyelinating disease.

Youl BD, Kermode AG, Thompson AJ, Révész T, Scaravilli F, Barnard RO, Kirkham FJ, Kendall BE, Kingsley D, Moseley IF, et al. Youl BD, et al. Among authors: thompson aj. J Neurol Neurosurg Psychiatry. 1991 Apr;54(4):288-92. doi: 10.1136/jnnp.54.4.288. J Neurol Neurosurg Psychiatry. 1991. PMID: 2056314 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results